Ken Griffin's position in Design Therapeutics is currently worth $8.23 Million. That's 0.01% of their equity portfolio (1256th largest holding). The investor owns 3.05% of the outstanding Design Therapeutics stock. The first Design Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares five more times and sold shares on five occasions. The investor's estimated purchase price is $54.7 Million, resulting in a loss of 85%.